Company
United StatesPublic company, NASDAQ: VCELVericel Corporation (NASDAQ: VCEL), Cambridge, MA – FDA Inspections
Inspection records and compliance data for Vericel Corporation in Cambridge, Massachusetts. 7 FDA inspections on record, 3 Form 483s, last inspected June 12, 2026. Publicly traded as NASDAQ: VCEL.
Company Profile
This profile covers Vericel Corporation based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 5
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 3
- Warning letters
- 0
First inspected August 21, 2009. Last inspected June 12, 2026.
Most cited issue areas
- Procedures for sterile drug products3 inspections
- Investigations of discrepancies, failures2 inspections
- Acceptance criteria for sampling & testing1 inspection
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 12, 2026 | Not classified | Biologics · Blood and Blood Products | 1322008 |
| September 25, 2024 | VAI | Medical Devices & Rad Health · Compliance: Medical Devices | 1249999 |
| July 21, 2023 | NAI | Biologics, Medical Devices & Rad Health · Compliance: Devices | 1210597 |
| May 27, 2016 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1006746 |
| March 19, 2014 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 870615 |
| September 27, 2011 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 747422 |
| August 21, 2009 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 608350 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Vericel Corporation
Stock ticker
VCEL
Exchange
NASDAQ
Share price
$57.42
Market cap
$2.9B
Price as of
November 13, 2026
FEI Number
3002836339
Address
64 Sidney St, Cambridge, Massachusetts 02139, United States
Country
United States
ID: 1955c523-5115-491b-a705-2c526deb9ff6